Can rheumatoid arthritis cause bursitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can RA Cause Bursitis?

Yes, rheumatoid arthritis definitively causes bursitis as a direct manifestation of the inflammatory disease process, affecting multiple bursal sites throughout the body.

Understanding RA-Associated Bursitis

Bursitis in rheumatoid arthritis is not merely coincidental but represents a well-recognized extra-articular or peri-articular manifestation of the disease. The inflammatory process that characterizes RA extends beyond synovial joints to involve bursae, which are synovial-lined structures.

Common Bursal Sites Affected in RA

Forefoot bursitis is particularly prevalent in RA patients, including:

  • Intermetatarsal bursitis (IMB): Negatively associated with disease duration, meaning it appears earlier in the disease course 1
  • Submetatarsal bursitis (SMB): Associated with higher BMI and the presence of erosions 1

Shoulder bursitis frequently occurs, including:

  • Subacromial bursitis
  • Coracoid bursitis
  • Can present with severe inflammation requiring intensive anti-rheumatic treatment 2
  • May develop rice body formation in chronic cases 3

Other sites documented in RA include:

  • Scapulothoracic bursae
  • Ischiogluteal bursae
  • Trochanteric bursae 4

Clinical Recognition and Diagnosis

Key Clinical Associations

For intermetatarsal bursitis:

  • Opening toes sign on examination
  • Hammer toe deformity
  • Earlier disease presentation 1

For submetatarsal bursitis:

  • Elevated BMI
  • Presence of erosions on imaging
  • Foot architectural deformity 1

Diagnostic Approach

When bursitis is suspected in RA patients, the EULAR guidelines emphasize confirming inflammatory activity 5. Ultrasonography is the preferred initial imaging modality when there is doubt about inflammatory activity, showing excellent agreement with MRI (97.14% agreement, kappa=0.801) 1.

MRI provides comprehensive assessment when:

  • US findings are equivocal
  • Surgical planning is needed
  • Deep bursae require evaluation

Both modalities demonstrate excellent interobserver reliability (US: 98.73%, MRI: 98.41%) 1.

Clinical Implications

Distinguishing RA-Related Bursitis from Other Causes

This is critical because the EULAR guidelines for difficult-to-treat RA specifically warn that misdiagnosis or coexistent mimicking diseases must be considered 5. However, when bursitis occurs in established RA with documented inflammatory activity, it represents true disease manifestation rather than a mimic.

Treatment Considerations

Conservative management should follow standard RA treatment protocols:

  • Optimization of DMARD therapy targeting the underlying inflammatory process
  • Custom foot orthoses for forefoot bursitis (reduces pain and improves function) 6
  • Therapeutic footwear for weight-bearing bursae 6

Intensive therapy may be required for severe cases:

  • High-dose corticosteroids
  • Biologic DMARD optimization
  • Cases with gas formation or severe inflammation require aggressive anti-inflammatory treatment 2

Surgical intervention is reserved for:

  • Failed conservative management
  • Significant functional impairment
  • Synovectomy and bursa excision can provide symptom relief 7, 3

Important Caveats

Infection must be excluded when bursitis presents with:

  • Gas formation on imaging
  • Rapid progression despite treatment
  • Systemic signs of infection
  • Culture and pathological examination may be necessary 2

Disease activity assessment is paramount - the presence of bursitis should prompt evaluation of overall RA control, as it may indicate inadequate disease suppression requiring treatment escalation 4, 2.

The relationship between bursitis and disease duration varies by site, with intermetatarsal bursitis appearing earlier and potentially serving as an early indicator of inadequate disease control 1.

Related Questions

What are the possible etiologies of multiple bursitis sites in a 54-year-old female?
What are the recommended evaluation and management steps for a 12-year-old with worsening bilateral ankle pain, no trauma history, and a mother who was diagnosed with rheumatoid arthritis at the same age?
What is the appropriate evaluation and management for a patient with a family history of rheumatoid arthritis who presents with new‑onset ankle pain without an obvious cause?
How do you treat intermetatarsal bursitis with orthotics (Orthotic devices) as a podiatrist (Doctor of Podiatric Medicine)?
How should a long‑term rheumatoid arthritis patient on chronic immunosuppressive therapy (aromocoyle‑pritis) with left shoulder anterior and superior pain, night pain, and inability to raise the arm above shoulder height after a fall be evaluated and managed, given one month of physical therapy with minimal improvement and a pending MRI?
What is the safest stimulant medication for a pregnant adult who requires pharmacologic therapy?
How should Auvelity (dextromethorphan‑bupropion) be initiated and titrated in an adult patient with major depressive disorder who has not responded adequately to other antidepressants and has no history of seizure disorder, eating disorder, or recent MAO‑inhibitor use?
What is the recommended multimodal analgesic regimen for managing pain in the emergency department?
What is the appropriate nebulized dose of albuterol (Ventolin) and ipratropium bromide for a 16‑kg child?
In a man with benign prostatic hyperplasia, how do finasteride (5 mg daily) and tadalafil (5 mg daily) compare in terms of efficacy, onset of symptom relief, side effects, and long‑term management?
Is a 20 mg oral dose of megestrol acetate taken once daily an effective appetite stimulant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.